Composition, form of production and packaging
Capsules hard gelatinous в„–0, the case and a lid of green color; the content of the capsule is a powder from yellow-gray to gray-brown with a greenish tint with impregnations and a characteristic odor.
1 caps.
urolesanВ® extract is thick, in terms of moisture content 10% 10.7 mg, including h
carrot seed extract wild 1.84 mg
hops cone extract 6.33 mg
extract of common herb oregano 1.46 mg
peppermint oil 7.46 mg
fir oil 25.5 mg
Excipients: magnesium hydroxycarbonate 131.96 mg, lactose monohydrate 50.1 mg, castor oil 35.15 mg, magnesium aluminometasilicate 27.11 mg, talc 6.38 mg, potato starch 5.62 mg, disodium edetate dihydrate 0.02 mg.
The composition of the capsule: dye quinoline yellow 0.96 mg, titanium dioxide 0.77 mg, iron oxide oxide yellow 0.29 mg, dye blue patented 0.15 mg, gelatin to 96 mg.
10 pieces. - Al / PVC blisters (4) - cardboard packs.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2014.
PHARMACHOLOGIC EFFECT
The drug has antispasmodic, anti-inflammatory, antiseptic effect, increases bile formation and bile secretion, raises diuresis, acidifies urine, increases the release of urea and chlorides.
PHARMACOKINETICS
Uroleansan В® is a complex of biologically active components, therefore it is not possible to carry out its pharmacokinetic studies.
INDICATIONS
- in the complex therapy of acute and chronic infections of the urinary tract and kidneys (cystitis, pyelonephritis);
- urolithiasis disease;
- cholelithiasis;
- chronic cholecystitis;
- dyskinesia of bile ducts in hyperkinetic type.
DOSING MODE
The drug is used inside, before meals, 1 capsule 3 times a day. In the case of kidney and liver colic, a single dose can be increased once to 2 capsules, then in subsequent cases return to the usual single dose (1 capsule). Capsules should be taken without chewing, with a small amount of water.
In acute conditions (including renal and hepatic colic), the duration of therapy is 5 to 7 days, with chronic conditions - up to 1 month. An increase in the duration and conduct of a repeat course of treatment is possible only on the recommendation of a doctor.
SIDE EFFECT
On the part of the digestive system: dyspeptic phenomena (heartburn, nausea, vomiting, diarrhea);
Allergic reactions: itching, redness of the face, skin rash, angioedema (feeling of perspiration in the throat, difficulty breathing, swelling of the face, tongue);
From the central and peripheral nervous system: dizziness, general weakness;
From the cardiovascular system: increase / decrease in blood pressure.
CONTRAINDICATIONS
- hypersensitivity to the components of the drug;
- lactose intolerance, lactase deficiency or glucose-galactase malabsorption;
- hyperacid gastritis, peptic ulcer of the stomach and duodenum;
- The diameter of the kidney stones exceeds 3 mm;
- age to 18 years.
PREGNANCY AND LACTATION
The use of the drug during pregnancy and during breastfeeding is contraindicated (efficacy and safety have not been studied).
APPLICATION FOR FUNCTIONS OF THE LIVER
Contraindicated with a diameter of stones in the kidneys exceeding 3 mm.
APPLICATION FOR CHILDREN
Contraindicated in children under 18 years.
SPECIAL INSTRUCTIONS
Before using the drug, you should consult a doctor! In case of acute conditions, immediately consult a doctor!
For chronic conditions, if there is no effect on the background of taking the drug for 5-7 days, you should consult a doctor.
In case of side effects or unwanted reactions not listed in the instructions, you should stop taking the drug and consult a doctor.
Influence on ability to drive vehicles, mechanisms
In case of adverse reactions from the nervous system (dizziness), patients should refrain from engaging in potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions (vehicle management, work with moving mechanisms).
OVERDOSE
Possible increased dose-related side effects (including nausea, vomiting, dizziness).
Treatment symptomatic: abundant warm drink, peace, activated charcoal, atropine sulfate (0.0005-0.001 g).
DRUG INTERACTION
Not described.
TERMS OF RELEASE FROM PHARMACY
Without recipe.
TERMS AND CONDITIONS OF STORAGE
In the original packaging at a temperature of no higher than 25 В° C. Keep out of the reach of children. Shelf life - 2 years.
